BCDA
BioCardia, Inc.
Company overview
- Market capitalization
- $15.74M
- Employees
- 17
- Latest publication
- 2026-09-29
About BioCardia, Inc.
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States. The company's lead product candidate is CardiAMP, an autologous mononuclear cell therapy system in Phase III clinical trial for the treatment of ischemic heart failure with reduced ejection fraction and refractory angina resulting from chronic myocardial ischemia. It also provides CardiALLO, an allogeneic mesenchymal stem cell therapy which is in phase II for ischemic heart failure; allogeneic cell therapy platform; and PulmALLO, an allogeneic mesenchymal stem cell therapy for acute respiratory distress syndrome. In addition, the company offers the Helix biotherapeutic delivery system for minimally invasive targeted delivery of biologic agents to the heart; Heart3D for fusion imaging; and morph DNA and avance steerable introducers. It has a license and distribution agreement with Biomet Biologics, LLC. BioCardia, Inc. is based in Sunnyvale, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | -58,000USD | 58,000USD | 3,000USD |
| Cost Of Revenue | 124,000USD | 185,000USD | 107,000USD | 1,368,000USD | 1,530,000USD | 1,415,000USD | 108,000USD | 800,000USD |
| Gross Profit | -124,000USD | -185,000USD | -107,000USD | -1,368,000USD | -1,530,000USD | -1,415,000USD | -108,000USD | -797,000USD |
| Research Development | 1,235,000USD | 1,125,000USD | 932,000USD | 1,368,000USD | 1,530,000USD | 1,415,000USD | 931,000USD | 800,000USD |
| Selling General Administrative | 1,031,000USD | 885,000USD | 552,000USD | 683,000USD | 1,196,000USD | 906,000USD | 825,000USD | 852,000USD |
| Total Operating Expenses | 2,142,000USD | 1,828,000USD | 1,381,000USD | 683,000USD | 1,196,000USD | 906,000USD | 1,648,000USD | 852,000USD |
| Operating Income | -2,266,000USD | -2,013,000USD | -1,488,000USD | -2,051,000USD | -2,726,000USD | -2,321,000USD | -1,756,000USD | -1,649,000USD |
| Income Before Tax | -2,259,000USD | -1,984,000USD | -1,483,000USD | -2,049,000USD | -2,712,000USD | -2,296,000USD | -1,737,000USD | -1,646,000USD |
| Net Income | -2,259,000USD | -1,984,000USD | -1,483,000USD | -2,049,000USD | -2,712,000USD | -2,296,000USD | -1,737,000USD | -1,646,000USD |
| Net Income From Continuing Ops | -2,259,000USD | -1,984,000USD | -1,483,000USD | -2,049,000USD | -2,712,000USD | -2,296,000USD | -1,737,000USD | -1,646,000USD |
| Ebit | -2,266,000USD | -2,013,000USD | -1,483,000USD | -2,051,000USD | -2,726,000USD | -2,321,000USD | -1,737,000USD | -1,649,000USD |
| Ebitda | -2,142,000USD | -1,828,000USD | -1,376,000USD | -2,045,999USD | -2,714,000USD | -2,306,000USD | -1,629,000USD | -1,632,000USD |
| Depreciation And Amortization | 124,000USD | 185,000USD | 107,000USD | 5,001USD | 12,000USD | 15,000USD | 108,000USD | 17,000USD |
| Reconciled Depreciation | 3,000USD | 3,000USD | 4,000USD | 5,000USD | 12,000USD | 15,000USD | 16,000USD | 17,000USD |
| Total Other Income Expense Net | 7,000USD | 29,000USD | 5,000USD | 2,000USD | 14,000USD | 25,000USD | 19,000USD | 3,000USD |
| Unclassified Operating Expenses | — | — | — | -1,368,000USD | -1,530,000USD | -1,415,000USD | — | — |
| Income Tax Expense | — | — | — | — | — | -62,724USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 58,000USD | 477,000USD | 1,352,000USD | 1,015,000USD | 145,000USD | 710,000USD | 625,000USD |
| Cost Of Revenue | 505,000USD | 4,387,000USD | 7,726,000USD | 11,901,000USD | 640,000USD | 4,000USD | 358,000USD | 517,000USD |
| Gross Profit | -505,000USD | -4,329,000USD | -7,249,000USD | -10,549,000USD | 375,000USD | 141,000USD | 352,000USD | 108,000USD |
| Research Development | 4,962,000USD | 4,387,000USD | 7,726,000USD | 8,834,000USD | 8,558,000USD | 9,809,000USD | 8,562,000USD | 8,453,000USD |
| Selling General Administrative | 3,316,000USD | 3,672,000USD | 4,395,000USD | 4,419,000USD | 5,087,000USD | 5,861,000USD | 6,003,000USD | 5,757,000USD |
| Total Operating Expenses | 7,773,000USD | 3,671,999USD | 4,395,000USD | 13,253,000USD | 13,005,000USD | 15,670,000USD | 14,565,000USD | 14,210,000USD |
| Operating Income | -8,278,000USD | -8,000,999USD | -11,644,000USD | -11,901,000USD | -12,630,000USD | -15,529,000USD | -14,213,000USD | -14,102,000USD |
| Income Before Tax | -8,228,000USD | -7,946,000USD | -11,571,000USD | -11,907,000USD | -12,623,000USD | -15,004,000USD | -14,709,000USD | -13,987,000USD |
| Net Income | -8,228,000USD | -7,946,000USD | -11,571,000USD | -11,913,000USD | -12,621,000USD | -15,004,000USD | -14,709,000USD | -13,987,000USD |
| Net Income From Continuing Ops | -8,228,000USD | -7,946,000USD | -11,571,000USD | -11,907,000USD | -12,623,000USD | -15,004,000USD | -14,709,000USD | -13,987,000USD |
| Ebit | -8,278,000USD | -8,000,999USD | -11,644,000USD | -11,901,000USD | -12,630,000USD | -15,001,000USD | -14,597,000USD | -13,987,000USD |
| Ebitda | -7,773,000USD | -7,934,000USD | -11,560,000USD | -11,819,000USD | -12,570,000USD | -14,435,000USD | -14,046,000USD | -13,899,000USD |
| Depreciation And Amortization | 505,000USD | 66,999USD | 84,000USD | 82,000USD | 60,000USD | 566,000USD | 551,000USD | 88,000USD |
| Reconciled Depreciation | 24,000USD | 67,000USD | 84,000USD | 82,000USD | 60,000USD | 68,000USD | 111,000USD | 88,000USD |
| Total Other Income Expense Net | 50,000USD | 54,999USD | 73,000USD | -6,000USD | 7,000USD | 525,000USD | -496,000USD | 115,000USD |
| Unclassified Operating Expenses | — | -4,387,001USD | -7,726,000USD | — | — | — | — | — |
| Income Tax Expense | — | -7,946,000USD | 243,105USD | 6,000USD | -2,000USD | 1,000USD | 110,000USD | -115,000USD |
| Interest Expense | — | — | — | 6,000USD | 9,000USD | 3,000USD | 112,000USD | 118,000USD |
| Net Income Applicable To Common Shares | — | — | — | -11,907,000USD | -12,623,000USD | -15,004,000USD | -14,709,000USD | -13,987,000USD |
| Interest Income | — | — | — | — | 9,000USD | 21,000USD | 87,000USD | 118,000USD |
| Net Interest Income | — | — | — | — | 9,000USD | 18,000USD | -25,000USD | 118,000USD |
| Non Operating Income Net Other | — | — | — | — | — | 528,000USD | -384,000USD | 115,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 4,755,000USD | 1,712,000USD | 3,413,000USD | 6,148,000USD | 2,089,000USD | 2,166,000USD | 3,724,000USD | 6,267,000USD |
| Cash And Equivalents | 4,117,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 4,298,000USD | 1,140,000USD | 2,732,000USD | 5,365,000USD | 1,199,000USD | 1,173,000USD | 2,622,000USD | 5,056,000USD |
| Other Current Assets | 151,000USD | 169,000USD | 216,000USD | 78,000USD | 209,000USD | 224,000USD | 251,000USD | 116,000USD |
| Other Non Current Assets | 171,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 2,055,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 2,055,000USD | 2,778,000USD | 2,432,000USD | 3,310,000USD | 3,642,000USD | 3,234,000USD | 2,321,000USD | 2,840,000USD |
| Other Current Liabilities | 30,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 2,700,000USD | -1,066,000USD | 895,000USD | 2,627,000USD | -1,886,000USD | -1,520,000USD | 837,000USD | 2,753,000USD |
| Total Equity Including Noncontrolling Interest | 2,700,000USD | — | — | — | — | — | — | — |
| Net Receivables | 30,000USD | 20,000USD | 20,000USD | — | 10,000USD | — | 0USD | 10,000USD |
| Property Plant Equipment Net | 286,000USD | 401,000USD | 510,000USD | 612,000USD | 719,000USD | 822,000USD | 931,000USD | 1,040,000USD |
| Accounts Payable | 541,000USD | 820,000USD | 641,000USD | 1,080,000USD | 1,233,000USD | 818,000USD | 385,000USD | 569,000USD |
| Short Term Debt | 293,000USD | 412,000USD | 442,000USD | 427,000USD | 412,000USD | 398,000USD | 385,000USD | 371,000USD |
| Common Stock | 15,000USD | 11,000USD | 11,000USD | 11,000USD | 6,000USD | 5,000USD | 5,000USD | 5,000USD |
| Retained Earnings | -172,221,000USD | -170,608,000USD | -168,349,000USD | -166,365,000USD | -164,882,000USD | -162,833,000USD | -160,121,000USD | -157,825,000USD |
| Total Liab | — | 2,778,000USD | 2,518,000USD | 3,521,000USD | 3,975,000USD | 3,686,000USD | 2,887,000USD | 3,514,000USD |
| Other Current Liab | — | 1,546,000USD | 1,349,000USD | 1,264,000USD | 1,468,000USD | 1,486,000USD | 1,019,000USD | 1,900,000USD |
| Capital Stock | — | 11,000USD | 11,000USD | 11,000USD | 6,000USD | 5,000USD | 5,000USD | 5,000USD |
| Cash | — | 951,000USD | 2,496,000USD | 5,287,000USD | 980,000USD | 949,000USD | 2,371,000USD | 4,930,000USD |
| Cash And Short Term Investments | — | 951,000USD | 2,496,000USD | 5,287,000USD | 980,000USD | 949,000USD | 2,371,000USD | 4,930,000USD |
| Net Debt | — | -539,000USD | -1,968,000USD | -4,649,000USD | -235,000USD | -99,000USD | -1,420,000USD | -3,885,000USD |
| Short Long Term Debt Total | — | 412,000USD | 528,000USD | 638,000USD | 745,000USD | 850,000USD | 951,000USD | 1,045,000USD |
| Property Plant Equipment Gross | — | 1,189,000USD | 1,295,000USD | 1,394,000USD | 1,497,000USD | 1,595,000USD | 1,692,000USD | 1,786,000USD |
| Common Stock Shares Outstanding | — | 10,812,419shares | 10,755,647shares | 6,277,848shares | 5,059,736shares | 2,744,000shares | 2,744,000shares | 2,827,000shares |
| Non Current Assets Total | — | 572,000USD | 681,000USD | 783,000USD | 890,000USD | 993,000USD | 1,102,000USD | 1,211,000USD |
| Non Current Liabilities Total | — | 0USD | 86,000USD | 211,000USD | 333,000USD | 452,000USD | 566,000USD | 674,000USD |
| Non Currrent Assets Other | — | 171,000USD | 171,000USD | 171,000USD | 171,000USD | 171,000USD | 171,000USD | 171,000USD |
| Net Working Capital | — | -1,638,000USD | 300,000USD | 2,055,000USD | -2,443,000USD | -2,061,000USD | 301,000USD | 2,216,000USD |
| Unclassified Equity | — | 169,520,000USD | 169,222,000USD | 168,970,000USD | 162,984,000USD | 161,303,000USD | 160,948,000USD | 160,568,000USD |
| Current Deferred Revenue | — | — | — | 539,000USD | 529,000USD | 532,000USD | 532,000USD | 539,000USD |
| Accumulated Other Comprehensive Income | — | — | — | — | — | — | — | 0USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 3,413,000USD | 3,724,000USD | 2,987,000USD | 9,793,000USD | 15,718,000USD | 23,424,000USD | 7,678,000USD | 6,417,000USD |
| Other Current Assets | 216,000USD | 251,000USD | 295,000USD | 300,000USD | 462,000USD | 1,019,000USD | 642,000USD | 445,000USD |
| Total Liab | 2,518,000USD | 2,887,000USD | 4,590,000USD | 4,901,000USD | 5,343,000USD | 4,248,000USD | 5,308,000USD | 2,625,000USD |
| Total Stockholder Equity | 895,000USD | 837,000USD | -1,603,000USD | 4,892,000USD | 10,375,000USD | 19,176,000USD | 2,370,000USD | 3,792,000USD |
| Other Current Liab | 1,349,000USD | 1,019,000USD | 1,824,000USD | 1,622,000USD | 1,435,000USD | 2,888,000USD | 2,561,000USD | 1,528,000USD |
| Common Stock | 11,000USD | 5,000USD | 2,000USD | 20,000USD | 17,000USD | 16,000USD | 7,000USD | 43,000USD |
| Capital Stock | 11,000USD | 5,000USD | 24,000USD | 20,000USD | 17,000USD | 16,000USD | 7,000USD | 43,000USD |
| Retained Earnings | -168,349,000USD | -160,121,000USD | -152,175,000USD | -140,604,000USD | -128,697,000USD | -116,074,000USD | -101,070,000USD | -86,361,000USD |
| Cash | 2,496,000USD | 2,371,000USD | 1,103,000USD | 7,363,000USD | 12,872,000USD | 21,407,000USD | 5,585,000USD | 5,358,000USD |
| Cash And Short Term Investments | 2,496,000USD | 2,371,000USD | 1,103,000USD | 7,363,000USD | 12,872,000USD | 21,407,000USD | 5,585,000USD | 5,358,000USD |
| Total Current Assets | 2,732,000USD | 2,622,000USD | 1,461,000USD | 7,864,000USD | 13,481,000USD | 22,658,000USD | 6,378,000USD | 6,218,000USD |
| Total Current Liabilities | 2,432,000USD | 2,321,000USD | 3,608,000USD | 3,585,000USD | 3,712,000USD | 4,248,000USD | 4,003,000USD | 2,548,000USD |
| Net Debt | -1,968,000USD | -1,420,000USD | 212,000USD | -5,732,000USD | -11,004,000USD | -20,793,000USD | -4,443,000USD | -5,358,000USD |
| Short Term Debt | 442,000USD | 385,000USD | 333,000USD | 315,000USD | 237,000USD | 614,000USD | 528,000USD | — |
| Short Long Term Debt Total | 528,000USD | 951,000USD | 1,315,000USD | 1,631,000USD | 1,868,000USD | 614,000USD | 1,142,000USD | — |
| Net Receivables | 20,000USD | 0USD | 63,000USD | 201,000USD | 147,000USD | 232,000USD | 147,000USD | 274,000USD |
| Accounts Payable | 641,000USD | 385,000USD | 890,000USD | 683,000USD | 507,000USD | 746,000USD | 914,000USD | 1,020,000USD |
| Property Plant Equipment Net | 510,000USD | 931,000USD | 1,356,000USD | 1,757,000USD | 2,065,000USD | 712,000USD | 1,246,000USD | 145,000USD |
| Property Plant Equipment Gross | 1,295,000USD | 1,692,000USD | 2,050,000USD | 1,929,000USD | 2,602,000USD | 145,000USD | 1,246,000USD | 145,000USD |
| Common Stock Shares Outstanding | 6,666,943shares | 2,744,000shares | 1,412,000shares | 1,181,000shares | 1,128,000shares | 674,579shares | 376,289shares | 284,279shares |
| Non Current Assets Total | 681,000USD | 1,102,000USD | 1,527,000USD | 1,928,000USD | 2,237,000USD | 766,000USD | 1,300,000USD | 199,000USD |
| Non Current Liabilities Total | 86,000USD | 566,000USD | 982,000USD | 1,316,000USD | 1,631,000USD | 2,748,000USD | 1,305,000USD | 77,000USD |
| Non Currrent Assets Other | 171,000USD | 171,000USD | 171,000USD | 171,000USD | 172,000USD | 54,000USD | 54,000USD | 54,000USD |
| Net Working Capital | 300,000USD | 301,000USD | -2,147,000USD | 4,279,000USD | 9,769,000USD | 18,410,000USD | 2,375,000USD | 3,670,000USD |
| Unclassified Equity | 169,222,000USD | 160,948,000USD | 150,546,000USD | 145,456,000USD | 139,038,000USD | 135,218,000USD | 103,426,000USD | 90,067,000USD |
| Current Deferred Revenue | — | 532,000USD | 561,000USD | 965,000USD | 1,533,000USD | 683,000USD | 732,000USD | 757,000USD |
| Other Assets | — | — | -1,000USD | 1,000USD | 172,000USD | 621,000USD | 54,000USD | 54,000USD |
| Inventory | — | — | — | -201,000USD | 1USD | -850,000USD | 4,000USD | 141,000USD |
| Accumulated Other Comprehensive Income | — | — | — | 0USD | — | 0USD | 0USD | 0USD |
| Net Tangible Assets | — | — | — | 4,892,000USD | 10,375,000USD | 19,176,000USD | 2,370,000USD | 3,792,000USD |
| Unclassified Non Current Liabilities | — | — | — | 1,316,000USD | 1,631,000USD | 2,748,000USD | — | — |
| Other Liab | — | — | — | — | — | — | 691,000USD | 77,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 6,000USD |
| Stock Based Compensation | 222,000USD |
| Change To Account Receivables | -10,000USD |
| Change To Liabilities | 209,000USD |
| Change In Working Capital | 47,000USD |
| Operating Cash Flow | -3,394,000USD |
| Capital Expenditures | -3,000USD |
| Investing Cash Flow | -3,000USD |
| Financing Cash Flow | 5,018,000USD |
| Change In Cash | 1,621,000USD |
| End Cash Flow | 4,117,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -2,259,000USD | -1,984,000USD | -1,483,000USD | -2,049,000USD | -2,712,000USD | -2,296,000USD | -1,737,000USD | -1,646,000USD |
| Depreciation | 3,000USD | 3,000USD | 4,000USD | 5,000USD | 12,000USD | 15,000USD | -71,000USD | 17,000USD |
| Stock Based Compensation | 113,000USD | 85,000USD | 77,000USD | 98,000USD | 170,000USD | 176,000USD | 177,000USD | 184,000USD |
| Other Non Cash Items | 121,000USD | 182,000USD | 103,000USD | 99,000USD | 97,000USD | 95,000USD | -475,000USD | 79,000USD |
| Change In Working Capital | 363,000USD | -783,000USD | -373,000USD | 198,000USD | 815,000USD | -563,000USD | -505,000USD | 54,000USD |
| Total Cash From Operating Activities | -1,659,000USD | -2,497,000USD | -1,672,000USD | -1,649,000USD | -1,618,000USD | -2,573,000USD | -2,611,000USD | -1,312,000USD |
| Capital Expenditures | -3,000USD | -6,000USD | 0USD | -1,000USD | 0USD | -1,000USD | -2,000USD | -3,000USD |
| Free Cash Flow | -1,662,000USD | -2,503,000USD | -1,672,000USD | -1,650,000USD | -1,618,000USD | -2,574,000USD | -2,613,000USD | -1,315,000USD |
| Total Cashflows From Investing Activities | -3,000USD | -6,000USD | — | -1,000USD | — | -1,000USD | -2,000USD | -3,000USD |
| Total Cash From Financing Activities | 117,000USD | -288,000USD | 5,979,000USD | 1,681,000USD | 196,000USD | 15,000USD | 6,122,000USD | 1,787,000USD |
| Issuance Of Capital Stock | 225,000USD | 0USD | 6,783,000USD | 1,695,000USD | 212,000USD | 39,000USD | 7,198,000USD | 1,849,000USD |
| Change In Cash | -1,545,000USD | -2,791,000USD | 4,307,000USD | 31,000USD | -1,422,000USD | -2,559,000USD | 3,509,000USD | 472,000USD |
| Begin Period Cash Flow | 2,496,000USD | 5,287,000USD | 980,000USD | 949,000USD | 2,371,000USD | 4,930,000USD | 1,421,000USD | 949,000USD |
| End Period Cash Flow | 951,000USD | 2,496,000USD | 5,287,000USD | 980,000USD | 949,000USD | 2,371,000USD | 4,930,000USD | 1,421,000USD |
| Other Cashflows From Financing Activities | 117,000USD | -197,000USD | — | — | -16,000USD | -24,000USD | -1,076,000USD | -62,000USD |
| Change To Account Receivables | — | -20,000USD | 10,000USD | -10,000USD | 0USD | 10,000USD | 0USD | 58,000USD |
| Investments | — | — | 0USD | — | — | -1,000USD | -2,000USD | -3,000USD |
| Sale Purchase Of Stock | — | — | — | — | — | — | 90,000USD | -62,000USD |
| Unclassified Financing Cash Flow | — | — | — | — | — | — | 7,108,000USD | 1,911,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -8,228,000USD | -7,946,000USD | -11,571,000USD | -11,907,000USD | -12,623,000USD | -15,004,000USD | -14,709,000USD | -13,987,000USD |
| Depreciation | 24,000USD | 67,000USD | 84,000USD | 82,000USD | 60,000USD | 68,000USD | 111,000USD | 88,000USD |
| Stock Based Compensation | 430,000USD | 741,000USD | 1,030,000USD | 1,183,000USD | 1,661,000USD | 2,952,000USD | 2,722,000USD | 2,774,000USD |
| Other Non Cash Items | 481,000USD | 329,000USD | 354,000USD | 295,000USD | 599,000USD | -506,000USD | 112,000USD | 2,961,000USD |
| Change To Account Receivables | -20,000USD | 97,000USD | 115,000USD | -54,000USD | 703,000USD | -703,000USD | 127,000USD | -179,000USD |
| Change In Working Capital | -143,000USD | -1,217,000USD | 129,000USD | -214,000USD | -63,000USD | 133,000USD | 1,409,000USD | 56,000USD |
| Total Cash From Operating Activities | -7,436,000USD | -8,026,000USD | -9,974,000USD | -10,561,000USD | -10,366,000USD | -12,357,000USD | -9,445,000USD | -11,069,000USD |
| Capital Expenditures | -7,000USD | -6,000USD | -12,000USD | -70,000USD | -116,000USD | -32,000USD | -146,000USD | -66,000USD |
| Free Cash Flow | -7,443,000USD | -8,032,000USD | -9,986,000USD | -10,631,000USD | -10,482,000USD | -12,389,000USD | -9,591,000USD | -11,135,000USD |
| Total Cashflows From Investing Activities | -7,000USD | -6,000USD | -12,000USD | -70,000USD | -116,000USD | -32,000USD | -146,000USD | -66,000USD |
| Total Cash From Financing Activities | 7,568,000USD | 9,300,000USD | 3,726,000USD | 5,122,000USD | 1,947,000USD | 28,211,000USD | 9,818,000USD | 3,804,000USD |
| Issuance Of Capital Stock | 8,690,000USD | 10,552,000USD | 4,388,000USD | 5,540,000USD | 2,001,000USD | 30,500,000USD | 10,452,000USD | 3,800,000USD |
| Change In Cash | 125,000USD | 1,268,000USD | -6,260,000USD | -5,509,000USD | -8,535,000USD | 15,822,000USD | 227,000USD | -7,331,000USD |
| Begin Period Cash Flow | 2,371,000USD | 1,103,000USD | 7,363,000USD | 12,872,000USD | 21,407,000USD | 5,585,000USD | 5,358,000USD | 12,689,000USD |
| End Period Cash Flow | 2,496,000USD | 2,371,000USD | 1,103,000USD | 7,363,000USD | 12,872,000USD | 21,407,000USD | 5,585,000USD | 5,358,000USD |
| Other Cashflows From Financing Activities | -197,000USD | -1,252,000USD | -662,000USD | -418,000USD | -54,000USD | -2,795,000USD | -1,259,000USD | -196,000USD |
| Investments | — | -6,000USD | -12,000USD | -70,000USD | -116,000USD | -32,000USD | -146,000USD | -66,000USD |
| Change To Liabilities | — | — | — | -502,000USD | -75,000USD | -176,000USD | 1,784,000USD | 294,000USD |
| Change To Inventory | — | — | — | — | 507,000USD | 4,000USD | 136,000USD | 49,000USD |
| Net Borrowings | — | — | — | — | 0USD | 506,000USD | 625,000USD | 625,000USD |
| Dividends Paid | — | — | — | — | — | -346,000USD | — | — |
| Sale Purchase Of Stock | — | — | — | — | — | -160,000USD | 9,193,000USD | 3,804,000USD |
| Cash And Cash Equivalents Changes | — | — | — | — | — | 15,822,000USD | 227,000USD | -7,331,000USD |
| Unclassified Financing Cash Flow | — | — | — | — | — | 31,006,000USD | 1,259,000USD | — |
| Other Cashflows From Investing Activities | — | — | — | — | — | — | — | -66,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | — | — | — | -2,961,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q4 2023Quarterly · 2023-12-31 | Product | Collaboration Agreement | 13,000 | USD | Legacy provider |
| Q4 2023Quarterly · 2023-12-31 | Product | Product | 0 | USD | Legacy provider |
| FY 2023Yearly · 2023-12-31 | Product | Collaboration Agreement | 477,000 | USD | 0001437749-24-009587 |
| FY 2023Yearly · 2023-12-31 | Product | Product | 0 | USD | 0001437749-24-009587 |
| Q3 2023Quarterly · 2023-09-30 | Product | Collaboration Agreement | 357,000 | USD | 0001437749-23-030938 |
| Q3 2023Quarterly · 2023-09-30 | Product | Product | 0 | USD | 0001437749-23-030938 |
| Q2 2023Quarterly · 2023-06-30 | Product | Collaboration Agreement | 43,000 | USD | 0001437749-23-022780 |
| Q2 2023Quarterly · 2023-06-30 | Product | Product | 0 | USD | 0001437749-23-022780 |
| Q1 2023Quarterly · 2023-03-31 | Product | Collaboration Agreement | 64,000 | USD | 0001437749-23-013580 |
| Q1 2023Quarterly · 2023-03-31 | Product | Product | 0 | USD | 0001437749-23-013580 |
| Q4 2022Quarterly · 2022-12-31 | Product | Collaboration Agreement | 106,000 | USD | Legacy provider |
| Q4 2022Quarterly · 2022-12-31 | Product | Product | 0 | USD | Legacy provider |
| FY 2022Yearly · 2022-12-31 | Product | Collaboration Agreement | 1,349,000 | USD | 0001437749-24-009587 |
| FY 2022Yearly · 2022-12-31 | Product | Product | 3,000 | USD | 0001437749-24-009587 |
| Q3 2022Quarterly · 2022-09-30 | Product | Collaboration Agreement | 210,000 | USD | 0001437749-23-030938 |
| Q3 2022Quarterly · 2022-09-30 | Product | Product | 2,000 | USD | 0001437749-23-030938 |
| Q2 2022Quarterly · 2022-06-30 | Product | Collaboration Agreement | 974,000 | USD | 0001437749-23-022780 |
| Q2 2022Quarterly · 2022-06-30 | Product | Product | 0 | USD | 0001437749-23-022780 |
| Q1 2022Quarterly · 2022-03-31 | Product | Collaboration Agreement | 59,000 | USD | 0001437749-23-013580 |
| Q1 2022Quarterly · 2022-03-31 | Product | Product | 1,000 | USD | 0001437749-23-013580 |
| FY 2021Yearly · 2021-12-31 | Product | Collaboration Agreement | 1,014,000 | USD | 0001437749-23-008312 |
| FY 2021Yearly · 2021-12-31 | Product | Product | 1,000 | USD | 0001437749-23-008312 |
| FY 2020Yearly · 2020-12-31 | Product | Collaboration Agreement | 132,000 | USD | 0001437749-22-007544 |
| FY 2020Yearly · 2020-12-31 | Product | Product | 13,000 | USD | 0001437749-22-007544 |
| FY 2019Yearly · 2019-12-31 | Product | Collaboration Agreement | 528,000 | USD | 0001437749-21-007543 |
| FY 2019Yearly · 2019-12-31 | Product | Product | 182,000 | USD | 0001437749-21-007543 |
| FY 2018Yearly · 2018-12-31 | Product | Collaboration Agreement | 343,000 | USD | 0001437749-20-007405 |
| FY 2018Yearly · 2018-12-31 | Product | Product | 282,000 | USD | 0001437749-20-007405 |
| FY 2017Yearly · 2017-12-31 | Product | Collaboration Agreement | 90,000 | USD | 0001437749-20-007405 |
| FY 2017Yearly · 2017-12-31 | Product | Product | 389,000 | USD | 0001437749-20-007405 |
| FY 2016Yearly · 2016-12-31 | Product | Collaboration Agreement | 59,000 | USD | 0001437749-19-006300 |
| FY 2016Yearly · 2016-12-31 | Product | Product | 517,000 | USD | 0001437749-19-006300 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.